Use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS).
- DOI
- 10.1016/j.neurot.2026.e01048
- Published
- 2026 Sep
- Container
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neurot.2026.e01048,
title = {Use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS).},
author = {Hirano M and Berardo A and Barca E and Emmanuele V and Larson A and Spinazzola A and Karaa A},
year = {2026},
journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
doi = {10.1016/j.neurot.2026.e01048},
url = {https://doi.org/10.1016/j.neurot.2026.e01048}
}RIS
TY - JOUR TI - Use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS). AU - Hirano M AU - Berardo A AU - Barca E AU - Emmanuele V AU - Larson A AU - Spinazzola A AU - Karaa A PY - 2026 JO - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics DO - 10.1016/j.neurot.2026.e01048 UR - https://doi.org/10.1016/j.neurot.2026.e01048 ER -
APA
M, H., A, B., E, B., V, E., A, L., A, S., & A, K. (2026). Use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS).. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2026.e01048
Source records
- pubmed · retrieved 2026-09-26T06:28:41.528Z